Neonatal-maternal factors and perfluoroalkyl substances in cord blood

Chemosphere

Volumn 92, Issue 7, 2013, Pages 843-850

  Lien, Guang Wen ^a   Huang, Ching Chun ^b   Wu, Kuen Yuh ^a   Chen, Mei Huei ^a   Lin, Chien Yu ^c   Chen, Chia Yang ^a   Hsieh, Wu Shiun ^b   Chen, Pau Chung ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

Author keywords

Cockroaches; Cosmetics; Dietary; Lifestyles; Pregnancy; Taiwan Birth Panel Study

Indexed keywords

COSMETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LINEAR REGRESSION; MASS SPECTROMETRY; OBSTETRICS; SURVEYS;

COCKROACHES; DIETARY; LIFESTYLES; PANEL STUDIES; PREGNANCY;

BLOOD;

2 (N ETHYLPERFLUOROOCTANE SULFONAMIDO)ACETIC ACID; 2 (N METHYLPERFLUOROOCTANE SULFONAMIDO)ACETIC ACID; COSMETIC; HALOACID; PERFLUORO COMPOUND; PERFLUOROALKYL SUBSTANCE; PERFLUORODECANOIC ACID; PERFLUORODODECANOIC ACID; PERFLUOROHEPTANOIC ACID; PERFLUORONONANOIC ACID; PERFLUOROOCTANESULFONAMIDE; PERFLUOROOCTANOIC ACID; PERFLUOROOCTANYL SULFONATE; PERFLUOROUNDECANOIC ACID; POTASSIUM PERFLUOROHEXANESULFONATE; UNCLASSIFIED DRUG;

BLOOD; CONCENTRATION (COMPOSITION); DEMOGRAPHY; FLUORINE; HOSPITAL SECTOR; LIFESTYLE; MATERNAL EFFECT; NEONATE; POLLUTION EXPOSURE; PREGNANCY; QUESTIONNAIRE SURVEY; WEIGHT;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD ANALYSIS; BODY MASS; COCKROACH; DIET; DIETARY INTAKE; EDUCATIONAL STATUS; ENVIRONMENTAL EXPOSURE; EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INFANT; LIFESTYLE; LIMIT OF QUANTITATION; MALE; MATERNAL AGE; MULTIPARA; PREGNANCY; PRENATAL EXPOSURE; PUERPERIUM; SEX DIFFERENCE; STRUCTURED QUESTIONNAIRE; TAIWAN; TANDEM MASS SPECTROMETRY; UMBILICAL CORD BLOOD; WEIGHT GAIN;

TAIWAN;

BLATTARIA;

EID: 84879461083     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.04.038     Document Type: Article

References (62)

1. Andersen M.E., Clewell H.J., Tan Y.M., Butenhoff J.L., Olsen G.W. Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys - probing the determinants of long plasma half-lives. Toxicology 2006, 227:156-164.
2. Apelberg B.J., Goldman L.R., Calafat A.M., Herbstman J.B., Kuklenyik Z., Heidler J., Needham L.L., Halden R.U., Witter F.R. Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ. Sci. Technol. 2007, 41:3891-3897.
3. Apelberg B.J., Witter F.R., Herbstman J.B., Calafat A.M., Halden R.U., Needham L.L., Goldman L.R. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ. Health Perspect. 2007, 115:1670-1676.
4. Bartell S.M., Calafat A.M., Lyu C., Kato K., Ryan P.B., Steenland K. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ. Health Perspect. 2010, 118:222-228.
5. Boiteux V., Dauchy X., Rosin C., Munoz J.F. National screening study on 10 perfluorinated compounds in raw and treated tap water in France. Arch. Environ. Contam. Toxicol. 2012, 63:1-12.
6. Brantsaeter A.L., Whitworth K.W., Ydersbond T.A., Haug L.S., Haugen M., Knutsen H.K., Thomsen C., Meltzer H.M., Becher G., Sabaredzovic A., Hoppin J.A., Eggesbo M., Longnecker M.P. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women. Environ. Int. 2013, 54C:74-84.
7. Brede E., Wilhelm M., Goen T., Muller J., Rauchfuss K., Kraft M., Holzer J. Two-year follow-up biomonitoring pilot study of residents' and controls' PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany. Int. J. Hyg. Environ Health 2010, 213:217-223.
8. Calafat A.M., Kuklenyik Z., Reidy J.A., Caudill S.P., Tully J.S., Needham L.L. Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the national health and nutrition examination survey (NHANES). Environ. Sci. Technol. 2007, 41:2237-2242.
9. Chang Y.C., Chen W.L., Bai F.Y., Chen P.C., Wang G.S., Chen C.Y. Determination of perfluorinated chemicals in food and drinking water using high-flow solid-phase extraction and ultra-high performance liquid chromatography/tandem mass spectrometry. Anal. Bioanal. Chem. 2012, 402:1315-1325.
10. Chen M.H., Ha E.H., Wen T.W., Su Y.N., Lien G.W., Chen C.Y., Chen P.C., Hsieh W.S. Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS ONE 2012, 7:e42474.
11. Cho S.C., Bhang S.Y., Hong Y.C., Shin M.S., Kim B.N., Kim J.W., Yoo H.J., Cho I.H., Kim H.W. Relationship between environmental phthalate exposure and the intelligence of school-age children. Environ. Health Perspect. 2010, 118:1027-1032.
12. D'Eon J.C., Mabury S.A. Is indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans?. Environ. Sci. Technol. 2011, 45:7974-7984.
13. Ericson I., Marti-Cid R., Nadal M., Van Bavel B., Lindstrom G., Domingo J.L. Human exposure to perfluorinated chemicals through the diet: intake of perfluorinated compounds in foods from the Catalan (Spain) market. J. Agric. Food Chem. 2008, 56:1787-1794.
14. Fei C., McLaughlin J.K., Tarone R.E., Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ. Health Perspect. 2007, 115:1677-1682.
15. Fraser A.J., Webster T.F., Watkins D.J., Nelson J.W., Stapleton H.M., Calafat A.M., Kato K., Shoeib M., Vieira V.M., McClean M.D. Polyfluorinated compounds in serum linked to indoor air in office environments. Environ. Sci. Technol. 2012, 46:1209-1215.
16. Fromme H., Tittlemier S.A., Volkel W., Wilhelm M., Twardella D. Perfluorinated compounds - exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 2009, 212:239-270.
17. Gibson H.M. Plasma volume and glomerular filtration rate in pregnancy and their relation to differences in fetal growth. J. Obstet. Gynaecol. Br. Commonw. 1973, 80:1067-1074.
18. Glynn A., Berger U., Bignert A., Ullah S., Aune M., Lignell S., Darnerud P.O. Perfluorinated alkyl acids in blood serum from primiparous women in sweden: serial sampling during pregnancy and nursing, and temporal trends 1996-2010. Environ. Sci. Technol. 2012.
19. Grice M.M., Alexander B.H., Hoffbeck R., Kampa D.M. Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. J. Occup. Environ. Med. 2007, 49:722-729.
20. The National Academies Press, 2009. Weight Gain During Pregnancy: Reexamining the Guidelines. Institute of Medicine, National Research Council. Washington.
21. Han X., Nabb D.L., Russell M.H., Kennedy G.L., Rickard R.W. Renal elimination of perfluorocarboxylates (PFCAs). Chem. Res. Toxicol. 2012, 25:35-46.
22. Hanhijarvi H., Ophaug R.H., Singer L. The sex-related difference in perfluorooctanoate excretion in the rat. Proc. Soc. Exp. Biol. Med. 1982, 171:50-55.
23. Hanssen L., Rollin H., Odland J.O., Moe M.K., Sandanger T.M. Perfluorinated compounds in maternal serum and cord blood from selected areas of South Africa: results of a pilot study. J. Environ. Monit. 2010, 12:1355-1361.
24. Haug L.S., Huber S., Becher G., Thomsen C. Characterisation of human exposure pathways to perfluorinated compounds - comparing exposure estimates with biomarkers of exposure. Environ. Int. 2011, 37:687-693.
25. Hinderliter P.M., Mylchreest E., Gannon S.A., Butenhoff J.L., Kennedy G.L. Perfluorooctanoate: placental and lactational transport pharmacokinetics in rats. Toxicology 2005, 211:139-148.
26. Hölzer J., Midasch O., Rauchfuss K., Kraft M., Reupert R., Angerer J., Kleeschulte P., Marschall N., Wilhelm M. Biomonitoring of perfluorinated compounds in children and adults exposed to perfluorooctanoate-contaminated drinking water. Environ. Health Perspect. 2008, 116:651-657.
27. Hsieh C.J., Hsieh W.S., Su Y.N., Liao H.F., Jeng S.F., Taso F.M., Hwang Y.H., Wu K.Y., Chen C.Y., Guo Y.L., Chen P.C. The Taiwan birth panel study: a prospective cohort study for environmentally- related child health. BMC Res. Notes 2011, 4:291.
28. Hundley S.G., Sarrif A.M., Kennedy G.L. Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. Drug Chem. Toxicol. 2006, 29:137-145.
29. Inoue K., Okada F., Ito R., Kato S., Sasaki S., Nakajima S., Uno A., Saijo Y., Sata F., Yoshimura Y., Kishi R., Nakazawa H. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ. Health Perspect. 2004, 112:1204-1207.
30. Kannan K., Corsolini S., Falandysz J., Fillmann G., Kumar K.S., Loganathan B.G., Mohd M.A., Olivero J., Van Wouwe N., Yang J.H., Aldoust K.M. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ. Sci. Technol. 2004, 38:4489-4495.
31. Kato K., Wong L.Y., Jia L.T., Kuklenyik Z., Calafat A.M. Trends in exposure to polyfluoroalkyl chemicals in the US population: 1999-2008. Environ. Sci. Technol. 2011, 45:8037-8045.
32. Knopp R.H., Bergelin R.O., Wahl P.W., Walden C.E. Relationships of infant birth size to maternal lipoproteins, apoproteins, fuels, hormones, clinical chemistries, and body weight at 36 weeks gestation. Diabetes 1985, 34(Suppl 2):71-77.
33. Krutzen E., Olofsson P., Back S.E., Nilsson-Ehle P. Glomerular filtration rate in pregnancy: a study in normal subjects and in patients with hypertension, preeclampsia and diabetes. Scand. J. Clin. Lab. Invest. 1992, 52:387-392.
34. Kudo N., Suzuki E., Katakura M., Ohmori K., Noshiro R., Kawashima Y. Comparison of the elimination between perfluorinated fatty acids with different carbon chain length in rats. Chem. Biol. Interact. 2001, 134:203-216.
35. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
36. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., Butenhoff J.L., Stevenson L.A. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol. Sci. 2003, 74:382-392.
37. Lien G.W., Wen T.W., Hsieh W.S., Wu K.Y., Chen C.Y., Chen P.C. Analysis of perfluorinated chemicals in umbilical cord blood by ultra-high performance liquid chromatography/tandem mass spectrometry. J. Chromatogr. B 2011, 879:641-646.
38. Lin A.Y., Panchangam S.C., Lo C.C. The impact of semiconductor, electronics and optoelectronic industries on downstream perfluorinated chemical contamination in Taiwanese rivers. Environ. Pollut. 2009, 157:1365-1372.
39. Longo L.D. Maternal blood volume and cardiac output during pregnancy: a hypothesis of endocrinologic control. Am. J. Physiol. 1983, 245:R720-729.
40. Midasch O., Drexler H., Hart N., Beckmann M.W., Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int. Arch. Occup. Environ. Health 2007, 80:643-648.
41. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., Stewart B., Foster W.G. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ. Res. 2008, 108:56-62.
42. Nolan L.A., Nolan J.M., Shofer F.S., Rodway N.V., Emmett E.A. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod. Toxicol. 2009, 27:231-238.
43. OECD, 2002. Co-operation on existing chemicals. Hazard assessment of perfluorooctane sulfonate (PFOS) and its salts. ENV/JM/RD17/FINAL, Paris.
44. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., Zobel L.R. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115:1298-1305.
45. Olsen G.W., Butenhoff J.L., Zobel L.R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod. Toxicol. 2009, 27:212-230.
46. Olsen G.W., Lange C.C., Ellefson M.E., Mair D.C., Church T.R., Goldberg C.L., Herron R.M., Medhdizadehkashi Z., Nobiletti J.B., Rios J.A., Reagen W.K., Zobel L.R. Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010. Environ. Sci. Technol. 2012, 46:6330-6338.
47. Paul A.G., Jones K.C., Sweetman A.J. A first global production, emission, and environmental inventory for perfluorooctane sulfonate. Environ. Sci. Technol. 2009, 43:386-392.
48. Renner R. Growing concern over perfluorinated chemicals. Environ. Sci. Technol. 2001, 35:154A-160A.
49. Sabolic I., Asif A.R., Budach W.E., Wanke C., Bahn A., Burckhardt G. Gender differences in kidney function. Pflugers. Arch. 2007, 455:397-429.
50. Savitz D.A., Stein C.R., Elston B., Wellenius G.A., Bartell S.M., Shin H.M., Vieira V.M., Fletcher T. Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-ohio valley. Environ. Health Perspect. 2012, 120:1201-1207.
51. Spliethoff H.M., Tao L., Shaver S.M., Aldous K.M., Pass K.A., Kannan K., Eadon G.A. Use of newborn screening program blood spots for exposure assessment: declining levels of perluorinated compounds in New York State infants. Environ. Sci. Technol. 2008, 42:5361-5367.
52. Stein C.R., Savitz D.A., Dougan M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am. J. Epidemiol. 2009, 170:837-846.
53. Taniyasu S., Kannan K., So M.K., Gulkowska A., Sinclair E., Okazawa T., Yamashita N. Analysis of fluorotelomer alcohols, fluorotelomer acids, and short- and long-chain perfluorinated acids in water and biota. J. Chromatogr. A 2005, 1093:89-97.
54. Tittlemier S.A., Pepper K., Seymour C., Moisey J., Bronson R., Cao X.L., Dabeka R.W. Dietary exposure of Canadians to perfluorinated carboxylates and perfluorooctane sulfonate via consumption of meat, fish, fast foods, and food items prepared in their packaging. J. Agric. Food Chem. 2007, 55:3203-3210.
55. USEPA, 2006. 2010/15 PFOA Stewardship Program Guidance on Reporting Emissions and Product Content.
56. Vanden Heuvel J.P., Davis J.W., Sommers R., Peterson R.E. Renal excretion of perfluorooctanoic acid in male rats: inhibitory effect of testosterone. J. Biochem. Toxicol. 1992, 7:31-36.
57. Wang I.J., Hsieh W.S., Chen C.Y., Fletcher T., Lien G.W., Chiang H.L., Chiang C.F., Wu T.N., Chen P.C. The effect of prenatal perfluorinated chemicals exposures on pediatric atopy. Environ. Res. 2011, 111:785-791.
58. Wang M., Park J.S., Petreas M. Temporal changes in the levels of perfluorinated compounds in California women's serum over the past 50 years. Environ. Sci. Technol. 2011, 45:7510-7516.
59. Washino N., Saijo Y., Sasaki S., Kato S., Ban S., Konishi K., Ito R., Nakata A., Iwasaki Y., Saito K., Nakazawa H., Kishi R. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ. Health Perspect. 2009, 117:660-667.
60. Whitworth K.W., Haug L.S., Baird D.D., Becher G., Hoppin J.A., Skjaerven R., Thomsen C., Eggesbo M., Travlos G., Wilson R., Cupul-Uicab L.A., Brantsaeter A.L., Longnecker M.P. Perfluorinated compounds in relation to birth weight in the Norwegian mother and child cohort study. Am. J. Epidemiol. 2012, 175:1209-1216.
61. Xu Z., Fiedler S., Pfister G., Henkelmann B., Mosch C., Volkel W., Fromme H., Schramm K.W. Human exposure to fluorotelomer alcohols, perfluorooctane sulfonate and perfluorooctanoate via house dust in Bavaria, Germany. Sci. Total Environ. 2013, 443:485-490.
62. Ylinen M., Hanhijarvi H., Jaakonaho J., Peura P. Stimulation by oestradiol of the urinary excretion of perfluorooctanoic acid in the male rat. Pharmacol. Toxicol. 1989, 65:274-277.